1. Home
  2. KYMR vs SEE Comparison

KYMR vs SEE Comparison

Compare KYMR & SEE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KYMR
  • SEE
  • Stock Information
  • Founded
  • KYMR 2015
  • SEE 1960
  • Country
  • KYMR United States
  • SEE United States
  • Employees
  • KYMR N/A
  • SEE N/A
  • Industry
  • KYMR Medicinal Chemicals and Botanical Products
  • SEE Major Chemicals
  • Sector
  • KYMR Health Care
  • SEE Industrials
  • Exchange
  • KYMR Nasdaq
  • SEE Nasdaq
  • Market Cap
  • KYMR 4.3B
  • SEE 5.1B
  • IPO Year
  • KYMR 2020
  • SEE N/A
  • Fundamental
  • Price
  • KYMR $59.94
  • SEE $36.23
  • Analyst Decision
  • KYMR Strong Buy
  • SEE Strong Buy
  • Analyst Count
  • KYMR 19
  • SEE 10
  • Target Price
  • KYMR $66.84
  • SEE $41.60
  • AVG Volume (30 Days)
  • KYMR 631.1K
  • SEE 1.3M
  • Earning Date
  • KYMR 11-04-2025
  • SEE 11-04-2025
  • Dividend Yield
  • KYMR N/A
  • SEE 2.24%
  • EPS Growth
  • KYMR N/A
  • SEE 13.73
  • EPS
  • KYMR N/A
  • SEE 3.09
  • Revenue
  • KYMR $43,735,000.00
  • SEE $5,331,600,000.00
  • Revenue This Year
  • KYMR $60.88
  • SEE N/A
  • Revenue Next Year
  • KYMR N/A
  • SEE $1.95
  • P/E Ratio
  • KYMR N/A
  • SEE $11.58
  • Revenue Growth
  • KYMR N/A
  • SEE N/A
  • 52 Week Low
  • KYMR $19.45
  • SEE $22.78
  • 52 Week High
  • KYMR $63.96
  • SEE $38.85
  • Technical
  • Relative Strength Index (RSI)
  • KYMR 55.80
  • SEE 64.32
  • Support Level
  • KYMR $55.66
  • SEE $32.57
  • Resistance Level
  • KYMR $63.36
  • SEE $36.37
  • Average True Range (ATR)
  • KYMR 3.07
  • SEE 0.91
  • MACD
  • KYMR -0.37
  • SEE 0.07
  • Stochastic Oscillator
  • KYMR 57.78
  • SEE 96.32

About KYMR Kymera Therapeutics Inc.

Kymera Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to reinventing the treatment of human disease through the development of, differentiated medicines that address health problems and that meaningfully improve patients' lives. It is committed to novel technologies to address targets that have known disease-causing biology, but which have not been drugged, or have been inadequately drugged, often based on limitations of existing technologies. Its approach is intended to discover and develop a new generation of medicines in a disease-agnostic manner. Its product pipelines are STAT6, TYK2, and IRAK4.

About SEE Sealed Air Corporation

Sealed Air is organized via two reporting segments. Food includes food packaging products like Cryovac, Darfresh, and OptiDure aimed primarily at meats. Protective includes Sealed Air's Bubble Wrap, Instapak, Jiffy mailers, and shrink film packaging systems that cater to industrial and e-commerce applications.

Share on Social Networks: